VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 225 filers reported holding VERACYTE INC in Q4 2022. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $395,487 | -32.4% | 17,711 | -22.9% | 0.00% | – |
| Q2 2023 | $585,071 | +158.2% | 22,971 | +108.9% | 0.00% | – |
| Q1 2023 | $226,586 | -1.6% | 10,994 | +13.2% | 0.00% | – |
| Q4 2022 | $230,371 | -49.8% | 9,708 | +13.6% | 0.00% | – |
| Q1 2021 | $459,000 | +10.6% | 8,547 | +0.8% | 0.00% | – |
| Q4 2020 | $415,000 | +7.0% | 8,475 | -29.0% | 0.00% | – |
| Q3 2020 | $388,000 | +37.6% | 11,940 | +9.7% | 0.00% | – |
| Q2 2020 | $282,000 | -62.8% | 10,887 | -65.1% | 0.00% | -100.0% |
| Q1 2020 | $758,000 | -43.6% | 31,186 | -35.2% | 0.00% | 0.0% |
| Q4 2019 | $1,343,000 | -50.9% | 48,107 | -57.8% | 0.00% | -66.7% |
| Q3 2019 | $2,737,000 | -6.5% | 114,057 | +11.1% | 0.00% | 0.0% |
| Q2 2019 | $2,927,000 | -20.1% | 102,662 | -29.9% | 0.00% | -25.0% |
| Q1 2019 | $3,665,000 | +179.6% | 146,490 | +40.6% | 0.00% | +300.0% |
| Q4 2018 | $1,311,000 | – | 104,175 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 121,880 | $2,718 | 2.56% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 209,653 | $4,675,262 | 1.93% |
| EFG Asset Management (North America) Corp. | 270,772 | $6,032,800 | 1.33% |
| ARK Investment Management | 8,409,106 | $187,523,064 | 1.29% |
| Nikko Asset Management Americas, Inc. | 3,293,645 | $72,130,826 | 0.83% |
| CLOUGH CAPITAL PARTNERS L P | 339,978 | $7,581,509 | 0.82% |
| Granahan Investment Management | 1,145,527 | $25,545,252 | 0.78% |
| OBERWEIS ASSET MANAGEMENT INC/ | 212,180 | $4,731,614 | 0.73% |
| Parkman Healthcare Partners LLC | 118,622 | $2,645,271 | 0.58% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 173,717 | $3,873,889 | 0.56% |